相关实验视频

Updated: May 5, 2026

Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta

Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta

Published on: September 12, 2017

通过交叉遗传学探索平滑肌细胞对大动脉疾病的起源依赖性

Ximeng Han^1,2, Yi Li¹, Enci Wang³

¹Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, China (X. Han, Y.L., L.S., B.H.).

|February 10, 2025

概括

一个新的遗传系统通过发育起源精确地准光滑肌肉细胞 (SMC) 来研究大动脉疾病. 这项研究揭示了特定的SMC起源如何影响大动脉动脉瘤的形成和完整性,有助于治疗的发展.

科学领域:

心血管生物学
发育生物学
遗传学

背景情况:

平滑肌细胞 (SMC) 的发育多样性是细分特异性大动脉疾病的关键.
目前的遗传方法限制了基于细胞起源的体内疾病易感性分析.
需要先进的遗传工具来研究动脉病并开发有针对性的疗法.

研究的目的:

开发一种先进的双重重组合酶介导的交叉基因系统,以精确地准来自不同发育来源的小鼠SMC.
使用该系统研究转化生长因子-β (TGF-β) 信号对不同大动脉段的影响.
分析特定基因 (Tgfbr2,Smad4) 在大动脉壁完整性和疾病中的作用.

主要方法:

使用原点特定的Dre驱动器 (Isl1-Dre,Wnt1-Dre,Meox1-DreER,Upk3b-Dre) 开发双重重组酶介导的交叉遗传系统.
在小鼠中应用该系统以向不同发育起源的SMC原始体.
结合单细胞RNA测序和选择性基因淘汰 (Tgfbr2,Smad4) 在特定的大动脉区域.

主要成果:

上升大动脉SMC中的Tgfbr2缺乏导致动脉瘤形成.
Smad4在保持大动脉壁完整性和大动脉SMC中的平衡中起着至关重要的作用.
该系统成功地追踪了SMC群体内的多种发育起源的细胞.

结论:

开发的基因向系统为研究源依赖性大动脉血管疾病提供了一个新的平台.
这种方法可以全面分析细胞系对SMC病理的贡献.
促进有针对性的研究和未来治疗性干预措施的开发.

关键词:

其他类型大动脉疾病发展起源血统追踪平滑肌细胞

更多相关视频

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...